In a study conducted in China, adults treated with 14 days of intravenous injections of ginkgo diterpene lactone meglumine (GDLM) — a combination of biologically active components of ginkgo biloba — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results